Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

South Korea · Delayed Price · Currency is KRW

6,390.00

-10.00 (-0.16%)

Sep 23, 2026, 3:30 PM KST

Kwang Dong Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,707,288	1,659,512	1,640,719	1,514,454	1,431,545	1,338,182
Revenue Growth	5.50%	1.15%	8.34%	5.79%	6.98%	7.59%
Gross Profit	311,624	298,955	296,982	297,891	279,995	272,312
Operating Income	33,540	31,046	30,097	42,070	38,244	44,936
Net Income	21,823	20,968	40,481	36,966	24,174	24,019
Earnings Per Share	478.79	521.09	1011.00	913.00	588.00	584.33
EPS Growth	-30.24%	-48.46%	10.73%	55.27%	0.63%	-47.78%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	177,703	227,690	165,450	206,181	208,632	187,701
Total Debt	300,928	303,208	285,921	235,641	138,006	132,046
Net Cash (Debt)	-123,225	-75,518	-120,471	-29,460	70,627	55,655
Net Cash Growth	-	-	-	-	26.90%	40.66%
Net Cash Per Share	-2705.29	-1876.71	-3008.73	-727.94	1719.22	1353.21

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	17,686	82,341	-12,153	-11,730	62,822	54,940
Capital Expenditures	-16,664	-29,862	-75,730	-34,785	-25,383	-23,795
Free Cash Flow	1,022	52,479	-87,883	-46,515	37,439	31,145
Free Cash Flow Growth	-	-	-	-	20.21%	77.30%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	18.25%	18.02%	18.10%	19.67%	19.56%	20.35%
Operating Margin	1.97%	1.87%	1.83%	2.78%	2.67%	3.36%
Pretax Margin	1.93%	1.87%	3.49%	3.24%	2.54%	2.57%
Profit Margin	1.28%	1.26%	2.47%	2.44%	1.69%	1.80%
FCF Margin	0.06%	3.16%	-5.36%	-3.07%	2.61%	2.33%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	100.000	-	-	-	100.000	100.000
Dividend Per Share Growth	0%	-	-	-	0%	0%
Dividend Yield	1.57%	-	-	-	1.75%	1.43%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	13.35	10.98	5.39	8.06	10.13	12.71
Forward PE	-	14.32	14.32	14.32	14.32	14.32
P/FCF Ratio	310.75	4.39	-	-	6.54	9.80
PS Ratio	0.19	0.14	0.13	0.20	0.17	0.23